Sidarrth Prasad, Erica M Jones, Mehari Gebreyohanns, Yoon Kwon, DaiWai M Olson, Jane A Anderson, Sean I Savitz, Salvador Cruz-Flores, Steven J Warach, Charlotte E Rhodes, Mark P Goldberg, Nneka L Ifejika
BACKGROUND: Tenecteplase (TNK) is gaining recognition as a novel therapy for acute ischemic stroke (AIS). Despite TNK offering a longer half-life, time and cost saving benefits and comparable treatment and safety profiles to Alteplase (ALT), the adoption of TNK as a treatment for AIS presents challenges for hospital systems. OBJECTIVE: Identify barriers and facilitators of TNK implementation at acute care hospitals in Texas. METHODS: This prospective survey used open-ended questions and Likert statements generated from content experts and informed by qualitative research...
January 23, 2024: Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association